Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,181.00    -15.50 (-1.30%)
Bid:
1,180.00
Ask:
1,181.50
Spread: 1.50 (0.127%)
Market Cap: £6.01b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Share buy-back programme

2 Mar 2026 07:00

RNS Number : 7470U
St. James's Place PLC
02 March 2026
 

St. James's Place plc

 

Share buy-back programme

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

Further to the announcement made on 25 February 2026, St. James's Place plc (the Company) announces that it is commencing a share buy-back programme to repurchase its ordinary shares, subject to a maximum consideration of £122.6 million. The programme will begin on 2 March 2026 and end no later than 31 August 2026. The sole purpose of the buy-back programme is to reduce the capital of the Company.

 

The programme will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc is (Morgan Stanley), pursuant to which Morgan Stanley shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company in accordance with the Company's current buy-back authority granted by shareholders. Morgan Stanley will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company (including, for the avoidance of doubt, in the case of any purchases made during closed periods).

 

Any purchase of ordinary shares done in relation to this announcement will be carried out on the London Stock Exchange and Multilateral Trading Facilities, as defined by the Directive 2014/65/EU on markets in financial instruments (including the delegated and implementing acts adopted under it) as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter, and executed in accordance with the Listing Rules and the company's general authority to make market purchases of shares. The shares will be purchased in accordance with the price and volume conditions set out in the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures as implemented, retained, amended, extended, re-enacted or otherwise given effect in the United Kingdom from 1 January 2021 and as amended or supplemented in the United Kingdom thereafter. The company will announce any market repurchase of ordinary shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. To the extent permitted by law, ordinary shares purchased under the programme will be cancelled.

 

 

Enquiries:

Hugh Taylor, Director - Investor Relations

Tel: 07818 075143

Angela Warburton, Director - Communications

Tel: 07442 479542

 

Brunswick Group:

 

Tel: 020 7404 5959

Eilis Murphy

 

Email: sjp@brunswickgroup.com  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKOBPKBKDABB
Date   Source Headline
1st Jun 202111:44 amRNSTotal Voting Rights
26th May 20217:00 amRNSCapital Markets Day and New Business Update
20th May 20214:48 pmRNSHolding(s) in Company
18th May 20213:09 pmRNSAdditional Listing
14th May 20211:18 pmRNSResult of AGM
7th May 20214:49 pmRNSDirector/PDMR Shareholding
4th May 20213:15 pmRNSDirector/PDMR Shareholding
4th May 202112:05 pmRNSHolding(s) in Company
4th May 202111:08 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSQ1 New Business Inflows and Funds under Management
27th Apr 20214:35 pmRNSHolding(s) in Company
8th Apr 20214:32 pmRNSAnnual Report & Notice of AGM
1st Apr 20213:07 pmRNSTotal Voting Rights
31st Mar 20215:03 pmRNSCorrection: Director/PDMR Shareholding
29th Mar 20215:10 pmRNSDirector/PDMR Shareholding
17th Mar 20219:14 amRNSAdditional Listing
16th Mar 20219:50 amRNSDirector/PDMR Shareholding
16th Mar 20217:09 amRNSDirectorate Change
5th Mar 202112:53 pmRNSDirector/PDMR Shareholding
2nd Mar 20212:57 pmRNSDirector/PDMR Shareholding
1st Mar 20214:52 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSFinal Results
1st Feb 20215:02 pmRNSBlock listing Interim Review
1st Feb 20213:52 pmRNSTotal Voting Rights
1st Feb 20213:48 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSQ4 New Business Inflows and Funds Under Management
8th Jan 20212:44 pmRNSTotal Voting Rights - Replacement
8th Jan 202110:21 amRNSAdditional Listing
4th Jan 202112:01 pmRNSTotal Voting Rights
17th Dec 20209:20 amRNSDirectorate Change
1st Dec 202010:05 amRNSTotal Voting Rights
6th Nov 20209:41 amRNSDirector Declaration
2nd Nov 202011:07 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSQ3 New Business Inflows and Funds under Management
26th Oct 20209:39 amRNSStatement re Letter from Primestone LLP
23rd Oct 20207:22 amRNSHolding(s) in Company
21st Oct 20201:51 pmRNSDirector Declaration
7th Oct 20201:36 pmRNSDirector/PDMR Shareholding
1st Oct 20201:28 pmRNSTotal Voting Rights
18th Sep 202011:03 amRNSHolding(s) in Company
1st Sep 202011:00 amRNSTotal Voting Rights
19th Aug 20203:57 pmRNSHolding(s) in Company
7th Aug 20204:42 pmRNSHolding(s) in Company
5th Aug 202011:20 amRNSHolding(s) in Company
3rd Aug 20205:07 pmRNSBlock listing Interim Review - Amendment
3rd Aug 20204:57 pmRNSBlock listing Interim Review
3rd Aug 202010:19 amRNSTotal Voting Rights
28th Jul 20205:22 pmRNSDirector/PDMR Shareholding
28th Jul 20204:24 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSInterim Statement for the 6 Months to 30 June 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.